Victor Alexandru

Dr. Victor Alexandru

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2026 in Life
Verified
Journal Article
Open access
PDF file
Victor AlexandruVictor Alexandru
Victor Alexandru
AMAlexia Manole
Alexia Manole
LGLigia Salomea Groza
Ligia Salomea Groza
Felicia ManoleFelicia Manole
Felicia Manole
Background: This scoping review screens modern literature in search of effective treatment approaches that target both upper and lower airway diseases. Methods: After the establishment of a research protocol, 227 potential articles were obtained through a logged search method. These were screened and narrowed down to 26 included articles. Data were extracted using a standardized data extraction form and were analyzed thematically and analytically. Results: The main integrated treatment approaches are biological (dupilumab was the most mentioned molecule) and non-biological (allergen immunotherapy, nasal saline irrigation, and endoscopic polypectomy). Data suggest that these approaches are effective in improving upper and lower airway outcomes and showcase a good safety profile. Conclusions: Patients with upper and lower airway diseases should benefit from integrated treatment approaches when possible.

3 October 2025 in Allergies
Verified
Journal Article
Open access
PDF file
Victor AlexandruVictor Alexandru
Victor Alexandru
Felicia ManoleFelicia Manole
Felicia Manole
AMAlexia Manole
Alexia Manole
Both allergic rhinitis and chronic rhinosinusitis with or without nasal polyps have important factors in common with asthma. They are often present simultaneously, they have similar pathogenesis processes, and they have synergistic effects on the clinical manifestations. There are also important considerations regarding the common treatment of these pathologies. Taking all these into account, it is possible to place these diseases under the “united airway disease” umbrella. However, matters such as embryologic origins, anatomy and function of the upper and lower airways, as well as cases where the aforementioned pathologies can be observed independently and have different treatment responses, make up reasonable counterarguments for the “united airway disease”. This narrative review attempts to put all these factors into perspective for a slightly better understanding of the complexity of this topic. We will take into consideration factors such as epidemiological data, pathogenesis and pathology, clinical considerations, and the benefits of a common treatment.

25 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FBFLORINA OLIVIA BUZDUG
FLORINA OLIVIA BUZDUG
MIMirela Indries
Mirela Indries
Victor AlexandruVictor Alexandru
Victor Alexandru
CSClaudia Elena Staniș
Claudia Elena Staniș
Felicia ManoleFelicia Manole
Felicia Manole
MRMarius Rus
Marius Rus
Background/Objectives: Broad-range bacterial 16S rRNA gene PCR followed by sequencing may improve the etiological diagnosis of infective endocarditis (IE), particularly when conventional cultures are negative. This systematic review and meta-analysis evaluated the overall molecular detection yield and incremental value of valve-tissue 16S molecular testing in surgically managed IE. Methods: PubMed/MEDLINE, Scopus, Web of Science Core Collection, and Europe PMC were searched for Open Access studies published from 2016 to 2026. Eligible studies evaluated broad-range bacterial 16S PCR with sequence-based identification on excised native or prosthetic heart-valve tissue. Random-effects generalized linear mixed models were used to pool overall diagnostic yield, strict blood-culture-negative IE (BCNE) yield, and strict incremental etiologic yield beyond conventional microbiology. Diagnostic accuracy was summarized descriptively when complete 2 × 2 data were available. Results: Eight studies comprising 925 patients, surgical cases, or IE episodes contributed to the primary analysis, with 704 study-reported molecular-positive results. The pooled diagnostic yield was 75.9% (95% CI, 68.7–82.0%), with substantial heterogeneity (I2 = 81.8%) and a 95% prediction interval of 49.2–91.2%. In strict BCNE, the pooled yield was 53.7% (95% CI, 41.2–65.8%). The strict incremental etiologic yield was 8.8% (95% CI, 6.1–12.5%). Sensitivity analyses yielded similar estimates. Conclusions: Valve-tissue 16S PCR/sequencing can provide valuable etiological information, particularly in BCNE. However, the substantial between-study heterogeneity and wide prediction interval indicate that its expected molecular detection yield varies considerably across clinical settings and is influenced by patient selection, local diagnostic algorithms, laboratory methods, and reference standards.